Pharmaniqe Research And Investment Llp

Pharmaniqe Research And Investment Llp

Develops pharmaceutical products through formulation and development laboratory.
2020 | Ahmedabad, Gujarat (India) | Active

Last Updated:

January 22, 2024
HomeCompanyPharmaniqe Research And Investment Llp

Who are the key members and board of directors at Pharmaniqe Research And Investment Llp?

Designated Partners(4)

NameDesignationAppointment DateStatus
Manglesh Desai Us Designated Partner 26-May-2020Current
Shipra Srivastava In Designated Partner 26-May-2020Current
Suchiben Patel In Designated Partner 26-May-2020Current
Manish Umrethia In Designated Partner 26-May-2020Current

Financial Performance of Pharmaniqe Research And Investment Llp.

Enhance accessibility to Pharmaniqe Research And Investment Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no Open Charges registered against the LLP as per our records.

How Many Employees Work at Pharmaniqe Research And Investment Llp?

Unlock and access historical data on people associated with Pharmaniqe Research And Investment Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Pharmaniqe Research And Investment Llp

Recent activity within the organization

  • Statement of Assets & Liabilities

    Pharmaniqe Research And Investment Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Ahmedabad.

    31 Mar 2023

  • Director Appointment

    Manglesh Dhirubhai Desai was appointed as a Designated Partner was appointed as a Designated Partner on 26 May 2020 & has been associated with this company since 4 years 7 months .

    26 May 2020

  • Director Appointment

    Shipra Srivastava was appointed as a Designated Partner was appointed as a Designated Partner on 26 May 2020 & has been associated with this company since 4 years 7 months .

    26 May 2020

  • Director Appointment

    Suchiben Patel was appointed as a Designated Partner was appointed as a Designated Partner on 26 May 2020 & has been associated with this company since 4 years 7 months .

    26 May 2020

  • Director Appointment

    Manish Kumar Labhendra Bhai Umrethia was appointed as a Designated Partner was appointed as a Designated Partner on 26 May 2020 & has been associated with this company since 4 years 7 months .

    26 May 2020

  • LLP Incorporation

    Pharmaniqe Research And Investment Llp was registered on 26 May 2020 with RoC-Ahmedabad & aged 4 years 7 months as per MCA records.

    26 May 2020

Frequently asked questions

  • Pharmaniqe Research And Investment Llp was incorporated on 26 May 2020.

  • The Obligation of Contribution of Pharmaniqe Research And Investment Llp is ₹ 1.00 M.

  • Currently 4 partners are associated with Pharmaniqe Research And Investment Llp.

    • Manglesh Dhirubhai Desai
    • Shipra Srivastava
    • Suchiben Patel
    • Manish Kumar Labhendra Bhai Umrethia
    Manglesh Dhirubhai DesaiShipra SrivastavaSuchiben PatelManish Kumar Labhendra Bhai Umrethia
  • As per Ministry of Corporate Affairs (Mca), the registered address of Pharmaniqe Research And Investment Llp is Plot No. 194, Medows 2 Gokuldham Village Sanathal Ta. Sanand Na, Ahmedabad, Gujarat, India, 382110.

  • The Limited Liability Partnership Identification Number (LLPIN) of Pharmaniqe Research And Investment Llp is AAS-4902.

  • The most recent Balance Sheet for Pharmaniqe Research And Investment Llp was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development